Patent · US Active

Injection device

US9623199B2 · kind B2 · utility

32Cited by

1References

20Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Frank Richter · Frankfurt, DE
Ross MacArthur · Sandbach, GB

Key dates

Filing date	Aug 12, 2013
Grant date	Apr 18, 2017
Priority date	—
Expiry date	Aug 12, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2205/584
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

The invention refers to an injection device comprising a delivery mechanism for injection of a medicament, preferably through a needle, and an end of dose mechanism comprising a feedback element, wherein the end of dose mechanism is operable to be activated at a position at which the delivery mechanism reaches the end of the dose and the end of dose mechanism is further operable to force the feedback element to move into a feedback direction which is opposite or parallel to the activation direction of a release button and/or into the longitudinal direction, wherein the activation direction is preferably a longitudinal direction of the device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.